Warning letter
Meditech Laboratories, Inc: warning letter of Oct 19, 2016
FDA warning letter 506537 · San Francisco District Office
Key facts
| Reference number | 506537 |
|---|---|
| Company | Meditech Laboratories, Inc |
| Subject | Drug Product/Adulterated |
| Issue date | Oct 19, 2016 |
| Posted date | Oct 19, 2016 |
| Issuing office | San Francisco District Office |
| Product type | Drugs |
| Inspection city | Las Vegas |
| Inspection ZIP | 89102 |
| Inspection start date | Mar 10, 2016 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: